JAFRON(SZ:300529) Sou Hu Cai Jing·2025-06-17 08:57Company Overview - Jianfan Biological Technology Group Co., Ltd. specializes in the research, production, and sales of biomaterials and high-tech medical devices [2] - The main products include various blood perfusion devices, dialysis solutions, disinfectants, and blood purification equipment [2] - The company has received multiple accolades, including being recognized as a key high-tech enterprise under the National Torch Program and a national champion in manufacturing [2] Financial Performance - For Q1 2025, the company reported a revenue of 548 million yuan, a year-on-year decrease of 26.40% [2] - The net profit for the same period was 189 million yuan, down 33.71% year-on-year, with a gross profit margin of 80.74% [2] Market Position - As of June 17, the company's stock closed at 21.16 yuan, with a rolling price-to-earnings (PE) ratio of 23.33 times [1] - The average PE ratio in the medical device industry is 49.80 times, with a median of 36.84 times, placing Jianfan Biological at the 51st position in the industry ranking [1][3] Shareholder Information - As of March 31, 2025, the number of shareholders for Jianfan Biological was 52,502, an increase of 5,451 from the previous count [1] - The average market value of shares held by each shareholder is 352,800 yuan, with an average holding of 27,600 shares [1]